Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May 15;16(5):102141.
doi: 10.4239/wjd.v16.i5.102141.

Construction of a risk prediction model for hypertension in type 2 diabetes: Independent risk factors and nomogram

Affiliations

Construction of a risk prediction model for hypertension in type 2 diabetes: Independent risk factors and nomogram

Jian-Yong Zhao et al. World J Diabetes. .

Abstract

Background: Type 2 diabetes mellitus (T2DM) is a prevalent metabolic disorder increasingly linked with hypertension, posing significant health risks. The need for a predictive model tailored for T2DM patients is evident, as current tools may not fully capture the unique risks in this population. This study hypothesizes that a nomogram incorporating specific risk factors will improve hypertension risk prediction in T2DM patients.

Aim: To develop and validate a nomogram prediction model for hypertension in T2DM patients.

Methods: A retrospective observational study was conducted using data from 26850 T2DM patients from the Anhui Provincial Primary Medical and Health Information Management System (2022 to 2024). The study included patients aged 18 and above with available data on key variables. Exclusion criteria were type 1 diabetes, gestational diabetes, insufficient data, secondary hypertension, and abnormal liver and kidney function. The Least Absolute Shrinkage and Selection Operator regression and multivariate logistic regression were used to construct the nomogram, which was validated on separate datasets.

Results: The developed nomogram for T2DM patients incorporated age, low-density lipoprotein, body mass index, diabetes duration, and urine protein levels as key predictive factors. In the training dataset, the model demonstrated a high discriminative power with an area under the receiver operating characteristic curve (AUC) of 0.823, indicating strong predictive accuracy. The validation dataset confirmed these findings with an AUC of 0.812. The calibration curve analysis showed excellent agreement between predicted and observed outcomes, with absolute errors of 0.017 for the training set and 0.031 for the validation set. The Hosmer-Lemeshow test yielded non-significant results for both sets (χ 2 = 7.066, P = 0.562 for training; χ 2 = 6.122, P = 0.709 for validation), suggesting good model fit.

Conclusion: The nomogram effectively predicts hypertension risk in T2DM patients, offering a valuable tool for personalized risk assessment and guiding targeted interventions. This model provides a significant advancement in the management of T2DM and hypertension comorbidity.

Keywords: Hypertension; Nomogram; Prediction model; Risk factors; Type 2 diabetes mellitus.

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest statement: The authors declared that they have no conflicts of interest regarding this work.

Figures

Figure 1
Figure 1
Screening of predictor variables using the LASSO regression model. A: Distribution of the LASSO coefficients of predictor factors; B: Selection of the optimal parameter λ in the LASSO model).
Figure 2
Figure 2
Risk prediction nomogram. LDL: Low-density lipoprotein; BMI: Body mass index.
Figure 3
Figure 3
receiver operating characteristic curve of diabetes with hypertension risk. A: Training group, B: Validation group. AUC: Area under the receiver operating characteristic curve.
Figure 4
Figure 4
Calibration curve of the nomogram for predicting diabetes with hypertension risk. A: Training group, B: Validation group.
Figure 5
Figure 5
Decision curve of diabetes with hypertension nomogram prediction model.

Similar articles

Cited by

References

    1. DeFronzo RA, Ferrannini E, Groop L, Henry RR, Herman WH, Holst JJ, Hu FB, Kahn CR, Raz I, Shulman GI, Simonson DC, Testa MA, Weiss R. Type 2 diabetes mellitus. Nat Rev Dis Primers. 2015;1:15019. - PubMed
    1. Song DK, Hong YS, Sung YA, Lee H. Risk factor control and cardiovascular events in patients with type 2 diabetes mellitus. PLoS One. 2024;19:e0299035. - PMC - PubMed
    1. Kamalumpundi V, Shams E, Tucker C, Cheng L, Peterson J, Thangavel S, Ofori O, Correia M. Mechanisms and pharmacotherapy of hypertension associated with type 2 diabetes. Biochem Pharmacol. 2022;206:115304. - PubMed
    1. Chakraborty S, Verma A, Garg R, Singh J, Verma H. Cardiometabolic Risk Factors Associated With Type 2 Diabetes Mellitus: A Mechanistic Insight. Clin Med Insights Endocrinol Diabetes. 2023;16:11795514231220780. - PMC - PubMed
    1. Elhefnawy ME, Ghadzi SMS, Noor Harun S. Predictors Associated with Type 2 Diabetes Mellitus Complications over Time: A Literature Review. J Vasc Dis. 2022;1:13–23.

LinkOut - more resources